The World Health Organization, WHO,
said Nigeria is going to be part of the vaccine clinical trials being developed
to combat COVID-19.
said Nigeria is going to be part of the vaccine clinical trials being developed
to combat COVID-19.
It was confirmed by the Nigerian head
of WHO, Fiona Braka, when speaking on COVID-19 Press briefing in Abuja at the
Presidential Task Force.
of WHO, Fiona Braka, when speaking on COVID-19 Press briefing in Abuja at the
Presidential Task Force.
She moreover uncovered that almost a
100 nations have communicated intrigued within the vaccines.
100 nations have communicated intrigued within the vaccines.
She stated, “Nigeria has also
expressed interest to be part of this solidarity trial and efforts are underway
to start the process in Nigeria too. Together with global health actors and
partners, over the past week, WHO launched the access to COVID-19 tools ACT
accelerator, a global collaboration to accelerate development for equitable
access to new COVID-19 diagnostics, therapeutics and vaccines.
expressed interest to be part of this solidarity trial and efforts are underway
to start the process in Nigeria too. Together with global health actors and
partners, over the past week, WHO launched the access to COVID-19 tools ACT
accelerator, a global collaboration to accelerate development for equitable
access to new COVID-19 diagnostics, therapeutics and vaccines.
“We have a total of 89 vaccines that
are in development globally, including seven in clinical evaluation and several
therapeutics are in clinical trials. WHO is committed to ensuring that as
medicines and vaccines are developed, they are shared equitably with all
countries and people.
are in development globally, including seven in clinical evaluation and several
therapeutics are in clinical trials. WHO is committed to ensuring that as
medicines and vaccines are developed, they are shared equitably with all
countries and people.
“We do have the solidarity trial which
is an international clinical trial to help find an effective treatment for
COVID-19, launched by the WHO and partners. More than 100 countries have joined
the solidarity trial and to date, over 1,200 patients have been randomized from
the first five countries to evaluate the safety and efficacy of full drug and
drug combinations.”
is an international clinical trial to help find an effective treatment for
COVID-19, launched by the WHO and partners. More than 100 countries have joined
the solidarity trial and to date, over 1,200 patients have been randomized from
the first five countries to evaluate the safety and efficacy of full drug and
drug combinations.”
